CanniMed Therapeutics Inc. and PharmaChoice Enter into Canada's First Exclusive Pharmacy Distribution Agreement for Medical Cannabis
CanniMed Therapeutics Inc. (TSX:CMED) ("CanniMed") and PharmaChoice today signed a letter of intent to collaborate on pharmacist education and the distribution, sale and marketing of medical cannabis products.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170302005765/en/
This industry-leading collaboration will see CanniMed responsible for producing and delivering accredited pharmacy education programs to PharmaChoic...